Clinical Trial Update: Efficacy of Ciclesonide Inhaled Once Daily Versus Fluticasone Propionate Inhaled Twice Daily in Children With Asthma (6 to 11 y) (BY9010/M1-206) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing once-daily inhaled ciclesonide to twice-daily inhaled fluticasone propionate in children aged 6 to 11 with asthma has completed, asses…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Fluticasone propionate (Fluticasone propionate)
• ciclesonide (ciclesonide)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED